PlainRecalls
FDA Devices Moderate Class II Ongoing

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

Reported: January 22, 2025 Initiated: October 7, 2024 #Z-0921-2025

Product Description

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

Reason for Recall

The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.

Details

Recalling Firm
DRG International, Inc.
Units Affected
10 units
Distribution
Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.
Location
Springfield, NJ

Frequently Asked Questions

What product was recalled?
DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361. Recalled by DRG International, Inc.. Units affected: 10 units.
Why was this product recalled?
The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 22, 2025. Severity: Moderate. Recall number: Z-0921-2025.